Inventor
STEINER MITCHELL S
US34 patents
⚠️ This page may combine multiple inventors who share the name “STEINER MITCHELL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GTX INC
12 patentsUS6899888B2May 31, 2005
Prevention and treatment of androgen-deprivation induced osteoporosis
GTX INC52 citations96
US7595402B2Sep 29, 2009
Prodrugs of selective androgen receptor modulators and methods of use thereof
GTX INC9 citations84
US10849873B2Dec 1, 2020
Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy
GTX INC1 citations73
US10258596B2Apr 16, 2019
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
GTX INC4 citations73
US9969683B2May 15, 2018
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
GTX INC3 citations73
US9744149B2Aug 29, 2017
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
GTX INC3 citations73
US9622992B2Apr 18, 2017
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
GTX INC3 citations73
US9604916B2Mar 28, 2017
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
GTX INC2 citations73
US9624161B2Apr 18, 2017
Estrogen receptor ligands and methods of use thereof
GTX INC4 citations72
US10314807B2Jun 11, 2019
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
GTX INC1 citations62
US7524866B2Apr 28, 2009
Prevention and treatment of androgen—deprivation induced osteoporosis
GTX INC3 citations62
US9051267B2Jun 9, 2015
Estrogen receptor ligands and methods of use thereof
GTX INC2 citations60
UNIV TENNESSEE RES FOUNDATION
8 patentsUS7026500B2Apr 11, 2006
Halogenated selective androgen receptor modulators and methods of use thereof
UNIV TENNESSEE RES FOUNDATION109 citations98
US6838484B2Jan 4, 2005
Formulations comprising selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION137 citations98
US8008348B2Aug 30, 2011
Treating muscle wasting with selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION31 citations92
US7855229B2Dec 21, 2010
Treating wasting disorders with selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION20 citations92
US7705182B2Apr 27, 2010
Multi-substituted selective androgen receptor modulators and methods of use thereof
UNIV TENNESSEE RES FOUNDATION28 citations92
US7547728B2Jun 16, 2009
Treating muscle wasting with selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION40 citations92
US7803970B2Sep 28, 2010
Multi-substitued selective androgen receptor modulators and methods of use thereof
UNIV TENNESSEE RES FOUNDATION19 citations84
US7776921B2Aug 17, 2010
Treating benign prostate hyperplasia with SARMS
UNIV TENNESSEE RES FOUNDATION11 citations83
UNIV TENNESSEE RES CORP
7 patentsUS6632447B1Oct 14, 2003
Method for chemoprevention of prostate cancer
UNIV TENNESSEE RES CORP58 citations95
US6410043B1Jun 25, 2002
Method for chemoprevention of prostate cancer
UNIV TENNESSEE RES CORP37 citations95
US6413534B1Jul 2, 2002
Method for chemoprevention of prostate cancer
UNIV TENNESSEE RES CORP21 citations92
US6413533B1Jul 2, 2002
Method for chemoprevention of prostate cancer
UNIV TENNESSEE RES CORP34 citations92
US6413535B1Jul 2, 2002
Method for chemoprevention of prostate cancer
UNIV TENNESSEE RES CORP33 citations92
US6265448B1Jul 24, 2001
Method for chemoprevention of prostate cancer
UNIV TENNESSEE RES CORP28 citations86
US6835812B1Dec 28, 2004
Human p-Hyde proteins
UNIV TENNESSEE RES CORP0 citations44